The Enterprise Value as of November 2024 (TTM) for Cadrenal Therapeutics, Inc. Common Stock (CVKD) is 20.50M

According to Cadrenal Therapeutics, Inc. Common Stock’s latest financial reports and current stock price. The company's current Enterprise Value is 20.50M. This represents a change of 361.71% compared to the average of 4.44M of the last 4 quarters.

Cadrenal Therapeutics, Inc. Common Stock (CVKD) Historical Enterprise Value (quarterly & annually)

How has CVKD Enterprise Value performed in the past?

The mean historical Enterprise Value of Cadrenal Therapeutics, Inc. Common Stock over the last ten years is 94.96M. The current 20.50M Enterprise Value has changed 2.06% with respect to the historical average. Over the past ten years (40 quarters), CVKD's Enterprise Value was at its highest in in the September 2022 quarter at 719.44M. The Enterprise Value was at its lowest in in the September 2023 quarter at -226786.00.

Cadrenal Therapeutics, Inc. Common Stock (CVKD) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cadrenal Therapeutics, Inc. Common Stock Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cadrenal Therapeutics, Inc. Common Stock (CVKD) Average Enterprise Value

How has CVKD Enterprise Value performed in the past?

The current Enterprise Value of Cadrenal Therapeutics, Inc. Common Stock (CVKD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cadrenal Therapeutics, Inc. Common Stock (CVKD) Enterprise Value vs. Peers

How is CVKD’s Enterprise Value compared to its peers?

Cadrenal Therapeutics, Inc. Common Stock’s Enterprise Value is less than Mineralys Therapeutics, Inc. (523.81M), less than Structure Therapeutics Inc. (1.75B), less than Centessa Pharmaceuticals plc (1.75B), less than Nuvectis Pharma, Inc. (81.37M), less than Senti Biosciences, Inc. (34.09M), less than ZIVO Bioscience, Inc. (73.95M), less than Foghorn Therapeutics Inc. (417.24M), greater than Quoin Pharmaceuticals, Ltd. (-162664.00), less than Ikena Oncology, Inc. (45.73M), less than Enochian Biosciences, Inc. (85.97M), less than Eliem Therapeutics, Inc. (119.64M), less than HCW Biologics Inc. (34.47M), less than Exicure, Inc. (45.02M), greater than Cingulate Inc. (5.36M), less than SAB Biotherapeutics, Inc. (24.24M), less than Anebulo Pharmaceuticals, Inc. (36.46M), less than Monopar Therapeutics Inc. (100.06M), greater than AN2 Therapeutics, Inc. (6.48M), less than Miromatrix Medical Inc. (90.06M), less than Inhibikase Therapeutics, Inc. (154.45M), less than PMV Pharmaceuticals, Inc. (47.77M),

Build a custom stock screener for Cadrenal Therapeutics, Inc. Common Stock (CVKD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cadrenal Therapeutics, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cadrenal Therapeutics, Inc. Common Stock (CVKD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cadrenal Therapeutics, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.